Site and Sequence Specificity of the Daunomycin-DNA Interaction

Biochemistry

Volumn 26, Issue 25, 1987, Pages 8227-8236

  Chaires, Jonathan B ^a   Fox, Keith R ^b   Herrera, Julio E ^b   Britt, Mark ^b   Waring, Michael J ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; DNA; RESTRICTION ENDONUCLEASE;

ANIMAL CELL; CATTLE; GENETIC ENGINEERING; PRIORITY JOURNAL; THYMUS;

ANIMALIA; BOS TAURUS;

EID: 0023549371     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi00399a031     Document Type: Article

References (60)

1. Arcamone, F. (1981) Doxorubicin: Anticancer Antibiotics, Academic Press, New York.
2. Beraldo, H., Garnier-Suillerot, A., Tosi, L., & Lavelle, F. (1985) Biochemistry 24, 284–289.
3. Brendel, V., Beckmann, J. S., & Trifonov, E. N. (1986) J. Biomol. Struct. Dyn. 4, 11–21.
4. Britt, M., Zunino, F., & Chaires, J. B. (1986) Mol. Pharmacol. 29, 74–80.
5. Chaires, J. B. (1983a) Nucleic Acids Res. 11, 8485–8494.
6. Chaires, J. B. (1983b) Biochemistry 22, 4204–4211.
7. Chaires, J. B. (1985a) Biopolymers 24, 403–419.
8. Chaires, J. B. (1985b) Biochemistry 24, 7479–7486.
9. Chaires, J. B. (1986) J. Biol. Chem. 261, 8899–8907.
10. Chaires, J. B., Dattagupta, N., & Crothers, D. M. (1982) Biochemistry 21, 3933–3940.
11. Chaires, J. B., Dattagupta, N., & Crothers, D. M. (1983) Biochemistry 22, 284–292.
12. Chaires, J. B., Dattagupta, N., & Crothers, D. M. (1985) Biochemistry 24, 260–267.
13. Chen, K.-X., Gresh, N., & Pullman, B. (1985) J. Biomol. Struct. Dyn. 3, 445–466.
14. Dabrowiak, J. C. (1983) Life Sci. 32, 2915–2931.
15. Dervan, P. B. (1986) Science (Washington, D.C.) 232, 464–471.
16. Dougherty, G., & Pigram, W. J. (1982) CRC Crit. Rev. Biochem. 12, 103–132.
17. Drew, H. R., & Travers, A. A. (1984) Cell (Cambridge, Mass.) 37, 491–502.
18. Eliot, H., Gianni, L., & Myers, C. (1984) Biochemistry 23, 928–936.
19. Fox, K. R., & Waring, M. J. (1984) Nucleic Acids Res. 12, 9271–9285.
20. Fox, K. R., & Howarth, N. R. (1985) Nucleic Acids Res. 13, 8695–8714.
21. Fox, K. R., & Waring, M. J. (1986a) Biochemistry 25, 4349–4356.
22. Fox, K. R., & Waring, M. J. (1986b) Nucleic Acids Res. 14, 2001–2014.
23. Fox, K. R., & Waring, M. J. (1987) Nucleic Acids Res. 15, 491–507.
24. Gale, E. F., Cundliffe, E., Reynolds, P. E., Richmond, M. H., & Waring, M. J. (1981) The Molecular Basis of Antibiotic Action, 2nd ed., Wiley, London.
25. Graves, D. E., & Krugh, T. R. (1983) Biochemistry 22, 3941–3947.
26. Hagen, F., Zarling, D. A., & Jovin, T. M. (1985) EMBO J. 4, 837–844.
27. Harshman, K. D., & Dervan, P. B. (1985) Nucleic Acids Res. 13, 4825–4835.
28. Herrera, J. E., Britt, M., & Chaires, J. B. (1987) Biophys. J. 51, 505a.
29. Kersten, W., Kersten, N., & Szybalski, W. (1966) Biochemistry 5, 236–244.
30. Khoury, G., & Gruss, P. (1983) Cell (Cambridge, Mass.) 33, 313–314.
31. Lane, M. J., Dabrowiak, J. C., & Vournakis, J. N. (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 3260–3264.
32. Lewin, B. (1983) Genes, Wiley, New York.
33. Low, C. M. L., Drew, H. R., & Waring, M. J. (1984a) Nucleic Acids Res. 12, 4865–4879.
34. Low, C. M. L., Olsen, R. K., & Waring, M. J. (1984b) FEBS Lett. 176, 414–420.
35. Low, C. M. L., Fox, K. R., & Waring, M. J. (1986) Anti-Cancer Drug Design 1, 149–160.
36. Malcolm, A. D. B., & Moffatt, J. R. (1981) Biochim. Biophys. Acta 655, 128–135.
37. Maniatis, T., Fritsch, E. F., & Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
38. Mariam, Y. H., & Glover, G. P. (1986) Biochem. Biophys. Res. Commun. 136, 1–7.
39. McGhee, J. D., & von Hippel, P. H. (1974) J. Mol. Biol. 86, 469–489.
40. Mueller, W., & Crothers, D. M. (1975) Eur. J. Biochem. 54, 267–277.
41. Mueller, W., Buenemann, H., & Dattagupta, N. (1975) Eur. J. Biochem. 54, 279–291.
42. Muindi, J., Sinha, B. K., Gianni, L., & Myers, C. (1985) Mol. Pharmacol. 27, 356–365.
43. Neidle, S., & Sanderson, M. R. (1983) in Molecular Aspects of Anti-Cancer Drug Action (Neidle, S., & Waring, M. J., Eds.) pp 35–57, Verlag Chemie, Weinlan.
44. Neidle, S., & Abraham, Z. (1984) CRC Crit. Rev. Biochem. 17, 73–121.
45. Newlin, D. D., Miller, K. J., & Pilch, D. F. (1984) Biopolymers 23, 139–158.
46. Nordheim, A., & Rich, A. (1983) Nature (London) 303, 674–679.
47. Patel, D. J., Kozlowski, S. A., & Rice, J. A. (1981) Proc. Natl. Acad. Sci. U.S.A. 78, 3333–3337.
48. Pustell, J., & Kafatos, F. C. (1982) Nucleic Acids Res. 10, 51–59.
49. Pustell, J., & Kafatos, F. C. (1984) Nucleic Acids Res. 12, 643–655.
50. Quigley, G. J., Wang, A.H.-J., Ughetto, G., van der Marel, G., van Boom, J. H., & Rich, A. (1980) Proc. Natl. Acad. Sci. U.S.A. 77, 7204–7208.
51. Robbie, M., & Wilkins, R. J. (1984) Chem.-Biol. Interact. 49, 189–207.
52. Scamrov, A. V., & Beabealashvilli, R. Sh. (1983) FEBS Lett. 164, 97–101.
53. Schutz, H., Gollmick, F. A., & Stutter, E. (1979) Stud. Biophys. 75, 147–159.
54. Van Dyke, M. W., & Dervan, P. B. (1983a) Biochemistry 22, 2373–2377.
55. Van Dyke, M. W., & Dervan, P. B. (1983b) Nucleic Acids Res. 11, 5555–5567.
56. Van Dyke, M. W., & Dervan, P. B. (1983c) Cold Spring Harbor Symp. Quant. Biol. 47, 347–353.
57. Van Dyke, M. W., & Dervan, P. B. (1984) Science (Washington, D.C.) 225, 1122–1127.
58. Van Dyke, M. W., Hertzberg, R. P., & Dervan, P. B. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 5470–5474.
59. Wang, A.H.-J., Ughetto, G., Quigley, G. J., & Rich, A. (1987) Biochemistry 26, 1152–1163.
60. Yen, S.-F., Germon, W., & Wilson, W. D. (1983) J. Am. Chem. Soc. 105, 3717–3719.